Back to top
more

ETF Quote Details

Previous Close 97.18
Open 96.85
Bid 96.43
Ask 96.46
Day Low-High 96.22-96.85
52wk Low-High 74.05-99.51
Volume 36,470
NAV (month end) 99.41
Premium (+)/Discount (-) (month end)-2.23

Zacks Premium Research for PPH

Zacks ETF Rank Buy 2
ETF Risk Med
ETF Research Report

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Expense Ratio

Expense Ratio 0.36%
Dividend (Yield) $1.54 (1.58%)
Issuer VAN ECK

Benchmark for PPH

MVIS US LISTED PHARMACEUTICAL 25 INDEX

The MVIS US Listed Pharmaceutical 25 Index tracks the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Fund Summary for PPH

VANECK PHARMACEUTICAL ETF

The VanEck Pharmaceutical ETF replicates as closely as possible, before fees and expenses, the price and yield performance of MVIS US Listed Pharmaceutical 25 Index.